
TUDOFOVIR 300mg tablet
Salt Composition: Tenofovir Disoproxil Fumerate
Expiry Date: 01/2028
Inclusive of all taxes
30 Tablet
About The Product
hepatitis B, HIV
Description
TUDOFOVIR 300mg tablet is an antiviral medicine with Tenofovir disoproxil fumarate as an active ingredient. It is used in the treatment of chronic hepatitis B virus (HBV) infection and also HIV infection in combination with other anti-HIV drugs.
It works by preventing the multiplication of viruses in human cells to stop the production of new viruses and clears up the infection from the body. It should be taken in dose and duration as advice by the doctor.
Don't take more than the recommended dose.
Uses
- Hepatitis B virus (HBV) infection
- Treatment of HIV infection
Side Effects
Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of TUDOFOVIR 300mg tablet include:
- Diarrhea
- Nausea
- Rash
- Weakness
- Vomiting
- Fatigue
- Abdominal pain
- Increased transaminase level in blood
- Decreased phosphate level in blood
- Pain
- Dizziness
- Depression
- Insomnia (difficulty in sleeping)
- Fever
- Itching
Contact your healthcare provider if you face any unusual or persistent side effects.
How To Use
- The dosage and treatment duration of the TUDOFOVIR 300mg tablet are decided by the doctor according overall patient's health.
- This tablet should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.
How It Works
- TUDOFOVIR 300mg tablet is an antiviral medicine with Tenofovir disoproxil fumarate as an active ingredient.
- It works by preventing the multiplication of viruses in human cells to stop the production of new viruses and clears up the infection from the body.
Safety Advice
FAQs
TUDOFOVIR 300mg is an antiviral medicine that works by blocking the replication of the virus to reduce its levels in the body.
Reference
- Nelson, M. R., Katlama, C., Montaner, J. S., Cooper, D. A., Gazzard, B., Clotet, B. ... & Rooney, J. F. (2007). The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. Aids, 21(10), 1273-1281.
- Hill, A., Hughes, S. L., Gotham, D., & Pozniak, A. L. (2018). Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? Journal of virus eradication, 4(2), 72-79.
- De Clercq, E. (2016). Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochemical pharmacology, 119, 1-7.
- Kearney, B. P., Flaherty, J. F., & Shah, J. (2004). Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clinical pharmacokinetics, 43(9), 595-612.
- Chapman, T. M., McGavin, J. K., & Noble, S. (2003). Tenofovir disoproxil fumarate. Drugs, 63(15), 1597-1608.
- Gallant, J. E., & Deresinski, S. (2003). Tenofovir disoproxil fumarate. Clinical Infectious Diseases, 37(7), 944-950.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
